Q3 2021 Holdings
Filed 2021-11-15 | 88 holdings | $564.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moderna IncPut | PUT | 60770K957 | $253 | 10,000 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $683 | 266,666 | 0.0% |
| Cellectar Biosciences Inc | COM PAR | 15117F500 | $851 | 920,000 | 0.0% |
| Surrozen Inc | COM | 86889P109 | $1.4K | 200,000 | 0.0% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $1.4K | 209,227 | 0.0% |
| Omega Alpha Spac | CL A | G6749V107 | $1.9K | 200,000 | 0.0% |
| Lifesci Acquisition II Corp | COM | 53229E103 | $2.0K | 200,000 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM NEW | 372427401 | $2.2K | 1,134,453 | 0.0% |
| Direxion SHS ETF TR(LABDUSD) | DAILY S&P BIOTEC | 25460G716 | $3.2K | 150,000 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $3.3K | 290,577 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $3.6K | 890,700 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $4.0K | 400,000 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $4.0K | 400,000 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $4.2K | 200,000 | 0.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $4.6K | 750,000 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $4.9K | 500,000 | 0.0% |
| Panacea Acquisition Corp II | CL A SHS | G6882C106 | $4.9K | 500,000 | 0.0% |
| Research Alliance Corp II | COM CL A | 760873109 | $4.9K | 500,000 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $5.0K | 500,000 | 0.0% |
| Assembly Biosciences Inc | COM | 045396108 | $5.2K | 1,500,000 | 0.0% |
| Gemini Therapeutics Inc | COM | 36870G105 | $5.3K | 1,300,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $5.5K | 687,000 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $7.3K | 450,000 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $8.0K | 2,913,091 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $8.9K | 3,734,574 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $9.5K | 450,000 | 0.0% |
| Immutep LTD(IMMP) | SPONSORED ADS | 45257L108 | $9.7K | 2,500,000 | 0.0% |
| Talis Biomedical Corp | COM | 87424L108 | $9.7K | 1,550,998 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $10.5K | 1,341,530 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $10.5K | 500,000 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $10.9K | 1,501,058 | 0.0% |
| Achilles Therapeutics PLC(698) | SPONSORED ADS | 00449L102 | $12.0K | 1,536,016 | 0.0% |
| F-Star Therapeutics Inc | COM | 30315R107 | $12.8K | 1,751,428 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $13.1K | 857,000 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $13.7K | 3,284,072 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $13.7K | 2,202,333 | 0.0% |
| Milestone Pharmaceuticals Inc(MIST) | COM | 59935V107 | $14.7K | 2,572,194 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $16.3K | 5,607,086 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $16.7K | 1,675,377 | 0.0% |
| Codiak Biosciences Inc(32W) | COM | 192010106 | $16.8K | 1,030,065 | 0.0% |
| Rain Therapeutics Inc | COM | 75082Q105 | $17.6K | 1,175,000 | 0.0% |
| Bellus Health Inc(BLU) | COM NEW | 07987C204 | $18.3K | 2,975,000 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $18.6K | 831,495 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $19.2K | 1,928,315 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $19.2K | 2,500,000 | 0.0% |
| Kura Oncology Inc.(KURA) | COM | 50127T109 | $19.7K | 1,050,289 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $20.2K | 686,347 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $21.4K | 300,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $22.2K | 2,325,000 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $22.3K | 1,334,227 | 0.0% |